Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study)

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

January 9, 2023

Study Completion Date

January 9, 2023

Conditions
Breast CancerMelanomaThoracic CancerLymphedema of Upper Arm
Interventions
OTHER

Ipsilateral peripheral IV insertion

Patients with successful ipsilateral intravenous access will be provided a patient education sheet describing signs and symptoms that should be reported to the study team. All participants will be contacted by the study team at twelve week intervals for 12 months after their radiology encounter for completion of symptom assessments. If a subject reports new signs or symptoms of lymphedema during follow-up, a clinic appointment for volumetric measurements and thorough evaluation will occur

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER